117 related articles for article (PubMed ID: 8996211)
1. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.
Moine P; Mazoit JX; Bédos JP; Vallée E; Azoulay-Dupuis E
J Pharmacol Exp Ther; 1997 Jan; 280(1):310-5. PubMed ID: 8996211
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
Gracia M; Martínez-Marín C; Huelves L; Giménez MJ; Aguilar L; Carcas A; Ponte C; Soriano F
Antimicrob Agents Chemother; 2005 Mar; 49(3):996-1001. PubMed ID: 15728894
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F
Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282
[TBL] [Abstract][Full Text] [Related]
5. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Li J; Zhang Y; Chen Y; Hao F; Chen Y
Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus pneumoniae pneumonia in mice: optimal amoxicillin dosing predicted from a pharmacokinetic-pharmacodynamic model.
Moine P; Mazoit JX
J Pharmacol Exp Ther; 1999 Dec; 291(3):1086-92. PubMed ID: 10565828
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
8. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin.
Amores R; Alou L; Giménez MJ; Sevillano D; Gómez-Lus ML; Aguilar L; Prieto J
Int J Antimicrob Agents; 2004 Jul; 24(1):79-82. PubMed ID: 15225866
[TBL] [Abstract][Full Text] [Related]
9. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
10. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
[TBL] [Abstract][Full Text] [Related]
11. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation.
Sevillano D; Calvo A; Giménez MJ; Alou L; Aguilar L; Valero E; Carcas A; Prieto J
J Antimicrob Chemother; 2004 Dec; 54(6):1148-51. PubMed ID: 15489246
[TBL] [Abstract][Full Text] [Related]
14. Pulsatile delivery of amoxicillin against Streptococcus pneumoniae.
Cha R; Rybak MJ
J Antimicrob Chemother; 2004 Dec; 54(6):1067-71. PubMed ID: 15486084
[TBL] [Abstract][Full Text] [Related]
15. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.
Sun HK; Lee SY; Banevicius MA; Du X; Maglio D; Nicolau DP
J Antimicrob Chemother; 2005 Sep; 56(3):559-65. PubMed ID: 16024590
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
18. The bactericidal activity of vancomycin and teicoplanin against Streptococcus pneumoniae.
Felmingham D; Foxall P; O'Hare M; Grüneberg R
Scand J Infect Dis Suppl; 1990; 72():20-5. PubMed ID: 2151062
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
[TBL] [Abstract][Full Text] [Related]
20. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Laguna B; Echeverría O; Carcas A; Lubomirov R; Casal J; Prieto J
J Antimicrob Chemother; 2005 May; 55(5):742-7. PubMed ID: 15761068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
